As expected, Imint’s delivered a weaker Q1 report negatively affected by volume caps and a generally weak smartphone quarter. It has, however, made solid progress during 2019 by signing seven new agreements. We expect Imint to return to high growth already during the upcoming quarters following the new contracts.
Read more and download the research update: http://bit.ly/2VXbCtv
Start following companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye – Research Powered Investment Banking. https://www.redeye.se/about/
